Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder

MG Miglis, CH Adler, E Antelmi, D Arnaldi… - The Lancet …, 2021 - thelancet.com
Patients with isolated rapid-eye-movement sleep behaviour disorder (RBD) are commonly
regarded as being in the early stages of a progressive neurodegenerative disease involving …

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies

P Magalhães, HA Lashuel - npj Parkinson's Disease, 2022 - nature.com
Abstract Parkinson's disease (PD), the second most common progressive
neurodegenerative disease, develops and progresses for 10–15 years before the clinical …

Detection of neuron-derived pathological α-synuclein in blood

A Kluge, J Bunk, E Schaeffer, A Drobny, W ** Parkinson disease
S Yan, C Jiang, A Janzen, TR Barber, A Seger… - JAMA …, 2024 - jamanetwork.com
IMPORTANCE Nonmotor symptoms of Parkinson disease (PD) often predate the movement
disorder by decades. Currently, there is no blood biomarker to define this prodromal phase …

Acceptor functionalization via green chemistry enables high‐performance n‐type organic electrochemical transistors for biosensing, memory applications

Y Wang, A Koklu, Y Zhong, T Chang… - Advanced Functional …, 2024 - Wiley Online Library
The organic electrochemical transistor (OECT) is one of the most versatile building blocks
within the bioelectronics device toolbox. While p‐type organic semiconductors have …

Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions

A Zarkali, GEC Thomas, H Zetterberg… - Nature …, 2024 - nature.com
A major challenge in Parkinson's disease is the variability in symptoms and rates of
progression, underpinned by heterogeneity of pathological processes. Biomarkers are …

Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention

YAR Mahaman, KS Embaye, F Huang, L Li, F Zhu… - Ageing research …, 2022 - Elsevier
Abstract Alzheimer's disease (AD), being the number one in terms of dementia burden, is an
insidious age-related neurodegenerative disease and is presently considered a global …

Emergence of extracellular vesicles as “liquid biopsy” for neurological disorders: boom or bust

A Kumar, MA Nader, G Deep - Pharmacological reviews, 2024 - Elsevier
Extracellular vesicles (EVs) have emerged as an attractive liquid biopsy approach in the
diagnosis and prognosis of multiple diseases and disorders. The feasibility of enriching …